Effect of <i>CTLA4</i> gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation

Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is being widely applied as a therapy for hematological malignancies. The long-term outcome of allo-HSCT depends directly on the ability of cytotoxic T-lymphocytes to recognize and eliminate the residual tumor. CTLA-4 is one o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: D. S. Romaniuk, A. A. Khmelevskaya, M. Yu. Drokov, N. N. Popova, V. A. Vasilieva, L. A. Kuzmina, G. A. Efimov, E. N. Parovichnikova, V. G. Savchenko
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: ABV-press 2019-04-01
Saila:Onkogematologiâ
Gaiak:
allogeneic hematopoietic stem cell transplantation
graft versus host disease
allele-specific polymerase chain reaction
nonsynonymous single nucleotide polymorphism
ctla4
Sarrera elektronikoa:https://oncohematology.abvpress.ru/ongm/article/view/337
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak